We are using cookies to implement functions like login, shopping cart or language selection for this website. Furthermore we use Google Analytics to create anonymized statistical reports of the usage which creates Cookies too. You will find more information in our privacy policy.
OK, I agree I do not want Google Analytics-Cookies
Quintessence International



Forgotten password?


Quintessence Int 45 (2014), No. 3     24. Jan. 2014
Quintessence Int 45 (2014), No. 3  (24.01.2014)

Page 239-243, doi:10.3290/j.qi.a31204, PubMed:24570991

Management of third molar removal with doses of native plasma-derived factor IX (Octanine) and local measures in a female patient with severe hemophilia B: A case report
Peisker, Andre / Kentouche, Karim / Raschke, Gregor Franziskus / Schultze-Mosgau, Stefan
Patients with hemophilia are at high risk of bleeding following oral surgery. As an X-linked recessive chromosomal bleeding disorder it is very rare in female patients. This is the first described case of management of third molar removal in a female patient suffering from severe hemophilia B. Excellent hemostasis was achieved by following a protocol using defined pre- and postoperative doses of factor IX and local hemostatic measures of collagen fleece, fibrin glue, primary suture, and tranexamic acid solution. Following defined protocols is essential in the management of oral surgery in patients with hemophilia and helps to prevent postoperative hemorrhages.

Keywords: bleeding disorder, factor replacement, female patient, hemophilia B, local measures, third molar removal